DK1001811T3 - Nanopartikler med en jernoxidholdig kerne omgivet af mindst to skaller - Google Patents

Nanopartikler med en jernoxidholdig kerne omgivet af mindst to skaller

Info

Publication number
DK1001811T3
DK1001811T3 DK98939520T DK98939520T DK1001811T3 DK 1001811 T3 DK1001811 T3 DK 1001811T3 DK 98939520 T DK98939520 T DK 98939520T DK 98939520 T DK98939520 T DK 98939520T DK 1001811 T3 DK1001811 T3 DK 1001811T3
Authority
DK
Denmark
Prior art keywords
core
shells
particles
iron oxide
shell
Prior art date
Application number
DK98939520T
Other languages
Danish (da)
English (en)
Inventor
Christoph Lesniak
Thomas Schiestel
Helmut Schmidt
Andreas Jordan
Original Assignee
Inst Neue Mat Gemein Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Neue Mat Gemein Gmbh filed Critical Inst Neue Mat Gemein Gmbh
Application granted granted Critical
Publication of DK1001811T3 publication Critical patent/DK1001811T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hard Magnetic Materials (AREA)
  • Compounds Of Iron (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98939520T 1997-06-20 1998-06-19 Nanopartikler med en jernoxidholdig kerne omgivet af mindst to skaller DK1001811T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19726282A DE19726282A1 (de) 1997-06-20 1997-06-20 Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
PCT/EP1998/003761 WO1998058673A1 (de) 1997-06-20 1998-06-19 Nanoskalige teilchen mit einem von mindestens zwei schalen umgebenen eisenoxid-haltigen kern

Publications (1)

Publication Number Publication Date
DK1001811T3 true DK1001811T3 (da) 2003-01-20

Family

ID=7833178

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98939520T DK1001811T3 (da) 1997-06-20 1998-06-19 Nanopartikler med en jernoxidholdig kerne omgivet af mindst to skaller

Country Status (10)

Country Link
US (2) US6541039B1 (enExample)
EP (1) EP1001811B1 (enExample)
JP (2) JP4902900B2 (enExample)
CN (1) CN1211127C (enExample)
AT (1) ATE223731T1 (enExample)
DE (2) DE19726282A1 (enExample)
DK (1) DK1001811T3 (enExample)
ES (1) ES2181256T3 (enExample)
PT (1) PT1001811E (enExample)
WO (1) WO1998058673A1 (enExample)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19726282A1 (de) * 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
US6306166B1 (en) * 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
DE19921088C2 (de) * 1999-04-30 2003-08-07 Magforce Applic Gmbh Stent zur Offenhaltung gangartiger Strukturen
DE19924138A1 (de) 1999-05-26 2000-11-30 Henkel Kgaa Lösbare Klebeverbindungen
DE19940220B4 (de) 1999-08-19 2007-05-03 Magforce Nanotechnologies Ag Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen
DE50015289D1 (de) * 1999-08-24 2008-09-11 Henkel Ag & Co Kgaa Verklebung durch Klebstoffe enthaltend nanoskalige Teilchen
DE19951599A1 (de) 1999-10-27 2001-05-23 Henkel Kgaa Verfahren zur adhesiven Trennung von Klebeverbunden
EP2343047B2 (en) 2000-02-08 2021-03-17 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
DE10020376A1 (de) * 2000-04-26 2001-11-08 Inst Zelltechnologie E V Dynamische Marker
DE10037883A1 (de) 2000-08-03 2002-02-14 Henkel Kgaa Ferromagnetische Resonanzanregung und ihre Verwendung zur Erwärmung teilchengefüllter Substrate
DE10037884A1 (de) 2000-08-03 2002-02-21 Henkel Kgaa Verfahren zur beschleunigten Klebstoffaushärtung
DE10141674A1 (de) 2000-09-01 2002-03-14 Henkel Kgaa Reaktionsklebstoff mit mindestens einer mikroverkapselten Komponente
US6997863B2 (en) * 2001-07-25 2006-02-14 Triton Biosystems, Inc. Thermotherapy via targeted delivery of nanoscale magnetic particles
US7074175B2 (en) * 2001-07-25 2006-07-11 Erik Schroeder Handy Thermotherapy via targeted delivery of nanoscale magnetic particles
US7951061B2 (en) * 2001-07-25 2011-05-31 Allan Foreman Devices for targeted delivery of thermotherapy, and methods related thereto
US7731648B2 (en) * 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
US20050013875A1 (en) * 2001-10-25 2005-01-20 Takeshi Kobayashi Immunopotentiators in thermotherapy for cancer
DE10163399A1 (de) 2001-12-21 2003-07-10 Sustech Gmbh & Co Kg Nanopartikuläre Zubereitung
DE10205332B4 (de) * 2002-02-06 2004-02-12 Berlin Heart Ag Verfahren zur Herstellung von magnetischen Nanoteilchen
AU2002361032A1 (en) * 2002-12-09 2004-06-30 Itn-Nanovation Gmbh Nanoscale core/shell particles and the production thereof
AU2003900335A0 (en) * 2003-01-22 2003-02-13 Sirtex Medical Limited Microparticles for selectively targeted hyperthermia
DE10331439B3 (de) 2003-07-10 2005-02-03 Micromod Partikeltechnologie Gmbh Magnetische Nanopartikel mit verbesserten Magneteigenschaften
US20050107870A1 (en) * 2003-04-08 2005-05-19 Xingwu Wang Medical device with multiple coating layers
US20050119725A1 (en) * 2003-04-08 2005-06-02 Xingwu Wang Energetically controlled delivery of biologically active material from an implanted medical device
DE10326538A1 (de) * 2003-06-12 2005-01-05 Institut für Neue Materialien Gemeinnützige GmbH Abriebfeste optische Schichten und Formkörper
DE10344449A1 (de) * 2003-09-25 2005-04-28 Henkel Kgaa Klebstoff-Zusammensetzung mit Barriere-Eigenschaften
US20050090732A1 (en) * 2003-10-28 2005-04-28 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles
DE10359252A1 (de) * 2003-12-17 2005-07-28 Siemens Ag Navigierte Wärmebehandlung von Tumoren mit enzymumhüllten Eisenpartikeln
US20060018835A1 (en) * 2004-04-02 2006-01-26 General Electric Company Nanoparticles with inorganic core and methods of using them
US7407816B2 (en) 2004-05-07 2008-08-05 Gentius, Inc Isoelectric particles and uses thereof
US7842281B2 (en) * 2004-05-10 2010-11-30 The Florida State University Research Foundation Magnetic particle composition for therapeutic hyperthermia
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
US20050260137A1 (en) * 2004-05-18 2005-11-24 General Electric Company Contrast agents for magnetic resonance imaging
DE102004038274A1 (de) * 2004-08-06 2006-03-16 Henkel Kgaa Bindemittel mit Barriere-Eigenschaften II
EP1803467A1 (en) * 2004-08-25 2007-07-04 Kagoshima University Composite fine particles and process for producing the same
DE102004052533A1 (de) † 2004-10-15 2006-05-04 Mykhaylyk, Olga, Dr. Magnetische Partikel zur Verwendung in Therapie und Diagnostik
DE102005016873A1 (de) 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
JP2008545665A (ja) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用
DE102005039579B4 (de) 2005-08-19 2022-06-30 Magforce Ag Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
DE102005060834A1 (de) 2005-12-20 2007-06-28 Grönemeyer Holding GmbH & Co. KG Magnetfeldapplikator
DE102006007564A1 (de) * 2006-02-16 2007-08-30 Röhm Gmbh Nanoskalige superparamagnetische Poly(meth)acrylatpolymere
JP2009527472A (ja) 2006-02-17 2009-07-30 トパス ゲーエムベーハー 細胞特異性を有する三区画ポリマーナノ粒子を使用した多モード撮像法概要
WO2007115291A2 (en) * 2006-04-04 2007-10-11 Freedom-2, Inc. Tissue markings with discrete absorption particles
EP1852107A1 (en) * 2006-04-19 2007-11-07 Nanobiotix Magnetic nanoparticles compositions and uses thereof
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
US9277295B2 (en) * 2006-06-16 2016-03-01 Cisco Technology, Inc. Securing media content using interchangeable encryption key
JP5001364B2 (ja) * 2006-07-04 2012-08-15 ブラッコ イメージング ソチエタ ペル アチオニ 腫瘍性組織等の生物組織を局部的に熱剥離するための装置
EP2056883B1 (en) 2006-08-04 2021-09-22 Baxter International Inc. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
KR101489830B1 (ko) * 2006-12-18 2015-02-04 콜로로삐아 이탈리아 에스.피.에이 발열요법에 적용하기 위한 자성 나노 입자, 그의 제조 및 약리 적용을 갖는 구조체에의 용도
US20080167548A1 (en) * 2007-01-04 2008-07-10 Sorensen Alma G Tissue Alteration With MRI RF Field
US20110104073A1 (en) * 2007-01-18 2011-05-05 Qi Zeng Iron/Iron Oxide Nanoparticle and Use Thereof
NZ588816A (en) 2007-01-21 2011-11-25 Hemoteq Ag Medical device for the treatment of stenoses of corporal lumina and for the prevention of impending restenoses
US20080281386A1 (en) * 2007-05-09 2008-11-13 Tessaron Medical, Inc. Systems and methods for treating body tissue
US20080281318A1 (en) * 2007-05-09 2008-11-13 Tessaron Medical, Inc. Systems and methods for inductive heat treatment of body tissue
US20090005734A1 (en) * 2007-06-27 2009-01-01 Tessaron Medical, Inc. Systems and methods for delivering particles into patient body
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
ES2320837B1 (es) * 2007-07-26 2010-03-04 Consejo Superior De Investigaciones Cientificas Dispositivo de hipertermia y su utilizacion con nanoparticulas.
US20090157069A1 (en) * 2007-12-06 2009-06-18 Curtis Tom Systems and methods for thermal treatment of body tissue
DE102008003615A1 (de) 2008-01-09 2009-07-16 Magforce Nanotechnologies Ag Magnetische Transducer
DE102008008522A1 (de) 2008-02-11 2009-08-13 Magforce Nanotechnologies Ag Implantierbare Nanopartikel-enthaltende Produkte
KR101101832B1 (ko) 2008-05-20 2012-01-05 연세대학교 산학협력단 열방출 나노 물질
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8323615B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8367427B2 (en) 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
DE102008064036B4 (de) * 2008-12-22 2012-06-06 Heraeus Medical Gmbh Polymethylmethacrylat-Knochenzement-Zusammensetzung zur kontrollierten Hyperthermiebehandlung und deren Verwendung
WO2010102066A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Dextran polymer powder for inhalation administration of pharmaceuticals
US8293213B2 (en) * 2009-03-12 2012-10-23 Palo Alto Research Center Incorporated Method and apparatus for thrombus removal using magnetic particles
EP2246376B1 (en) * 2009-04-27 2014-03-05 Leibniz-Institut für Polymerforschung Dresden e.V. Method for preparing particles with a conjugated polymer shell
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon
EP2453938B1 (en) * 2009-07-17 2015-08-19 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US9205155B2 (en) 2009-10-30 2015-12-08 General Electric Company Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents
US8565892B2 (en) * 2009-10-31 2013-10-22 Qteris, Inc. Nanoparticle-sized magnetic absorption enhancers having three-dimensional geometries adapted for improved diagnostics and hyperthermic treatment
CA2777841C (en) 2009-11-02 2017-01-17 Francis M. Creighton Magnetomotive stator system and methods for wireless control of magnetic rotors
DE102009058769A1 (de) 2009-12-16 2011-06-22 MagForce Nanotechnologies AG, 10589 Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
US20110160645A1 (en) * 2009-12-31 2011-06-30 Boston Scientific Scimed, Inc. Cryo Activated Drug Delivery and Cutting Balloons
US20120021010A1 (en) * 2010-04-29 2012-01-26 University Of Calcutta Antiplatelet agent and methods of using the same
US9669200B2 (en) 2010-08-06 2017-06-06 Boston Scientific Scimed, Inc. Systems and methods for the treatment of pelvic disorders including magnetic particulates
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
KR101173867B1 (ko) 2010-10-28 2012-08-14 삼성에스디아이 주식회사 리튬 이차 전지
US9180172B2 (en) 2010-12-15 2015-11-10 Ams Research Corporation Treatment of Peyronies disease
US8979797B2 (en) 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
CA2833413C (en) 2011-04-20 2020-09-22 The University Of Sydney A method for the treatment of a solid tumour
US9060938B2 (en) 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
ES2582283T3 (es) 2011-08-10 2016-09-12 Magforce Ag Dispositivo médico que comprende aglomerados de nanopartículas magnéticas recubiertas con alcoxisilano
WO2013021039A1 (en) 2011-08-11 2013-02-14 Basf Se Microwave absorbing composition
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
MX362089B (es) 2011-12-16 2019-01-07 Nanobiotix Nanopartículas que comprenden materiales metálicos y óxido de hafnio, preparación y usos de los mismos.
CN104204082B (zh) * 2012-02-07 2016-08-24 国立大学法人筑波大学 高分子化氮氧化合物与无机颗粒的有机-无机杂合复合物
US9883878B2 (en) 2012-05-15 2018-02-06 Pulse Therapeutics, Inc. Magnetic-based systems and methods for manipulation of magnetic particles
WO2014008378A1 (en) * 2012-07-06 2014-01-09 Mtd Products Inc Drive sprocket for a tracked utility vehicle
US9884662B2 (en) 2013-09-13 2018-02-06 Mtd Products Inc Suspension and lock-out systems for a partially tracked vehicle
EP3044081B1 (en) 2013-09-13 2020-04-15 MTD Products Inc. Drive sprocket for a tracked vehicle
WO2015056960A1 (ko) 2013-10-16 2015-04-23 주식회사 지니스 전자기파를 이용한 암 온열치료용 감작제 조성물 및 이를 이용한 암 치료 방법
US9902441B2 (en) 2014-08-21 2018-02-27 Mtd Products Inc Track drive
EA201792560A1 (ru) 2015-05-28 2018-06-29 Нанобиотикс Наночастицы для применения в качестве терапевтической вакцины
AU2016271322A1 (en) 2015-05-29 2017-12-07 Mtd Products Inc Utility vehicle
US11147874B2 (en) 2015-06-15 2021-10-19 Boston Scientific Scimed, Inc. Devices and methods for therapeutic heat treatment
DE102016006320A1 (de) 2016-05-25 2017-11-30 Carl Freudenberg Kg Fixierbare Flächengebilde
JP7051483B2 (ja) * 2017-03-29 2022-04-11 三洋化成工業株式会社 マイクロ波加熱溶着用樹脂組成物
US11511818B2 (en) 2017-09-05 2022-11-29 Mtd Products Inc Track drive
AU2018346586A1 (en) 2017-10-06 2020-03-12 Mtd Products Inc High-efficiency lawn maintenance tool and high-efficiency cutting blade
US11918315B2 (en) 2018-05-03 2024-03-05 Pulse Therapeutics, Inc. Determination of structure and traversal of occlusions using magnetic particles
US12171443B1 (en) 2021-03-09 2024-12-24 Pulse Therapeutics, Inc. Magnetically controlled flow generation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
FR2618084B1 (fr) * 1987-07-15 1989-11-10 Rhone Poulenc Chimie Microspheres magnetisables a base de polysiloxane, leur procede de preparation et leur application en biologie
EP0381742B1 (en) * 1988-08-04 1996-06-19 Advanced Magnetics Incorporated Receptor mediated endocytosis type mri contrast agents
US5460831A (en) * 1990-06-22 1995-10-24 The Regents Of The University Of California Targeted transfection nanoparticles
US5462751A (en) * 1990-06-22 1995-10-31 The Regeants Of The University Of California Biological and pharmaceutical agents having a nanomeric biodegradable core
DE4026978A1 (de) * 1990-08-25 1992-02-27 Bayer Ag Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
ATE207727T1 (de) * 1992-05-29 2001-11-15 Univ California Beschichtetes transplantat sowie herstellungsverfahren dafür
WO1994010983A1 (fr) * 1992-11-06 1994-05-26 Hisamitsu Pharmaceutical Co., Inc. Preparation pharmaceutique perorale liberable dans le tube digestif inferieur
US5547748A (en) * 1994-01-14 1996-08-20 Sri International Carbon nanoencapsulates
US6103379A (en) * 1994-10-06 2000-08-15 Bar-Ilan University Process for the preparation of microspheres and microspheres made thereby
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
US6022500A (en) * 1995-09-27 2000-02-08 The United States Of America As Represented By The Secretary Of The Army Polymer encapsulation and polymer microsphere composites
DE19614136A1 (de) * 1996-04-10 1997-10-16 Inst Neue Mat Gemein Gmbh Verfahren zur Herstellung agglomeratfreier nanoskaliger Eisenoxidteilchen mit hydrolysebeständigem Überzug
US5922537A (en) * 1996-11-08 1999-07-13 N.o slashed.AB Immunoassay, Inc. Nanoparticles biosensor
DE19726282A1 (de) * 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern

Also Published As

Publication number Publication date
CN1260724A (zh) 2000-07-19
US6979466B2 (en) 2005-12-27
JP4902900B2 (ja) 2012-03-21
DE19726282A1 (de) 1998-12-24
US20030180370A1 (en) 2003-09-25
US6541039B1 (en) 2003-04-01
EP1001811B1 (de) 2002-09-11
ES2181256T3 (es) 2003-02-16
EP1001811A1 (de) 2000-05-24
CN1211127C (zh) 2005-07-20
JP2010001308A (ja) 2010-01-07
DE59805535D1 (de) 2002-10-17
WO1998058673A1 (de) 1998-12-30
ATE223731T1 (de) 2002-09-15
PT1001811E (pt) 2003-01-31
JP5116743B2 (ja) 2013-01-09
JP2002507964A (ja) 2002-03-12

Similar Documents

Publication Publication Date Title
DK1001811T3 (da) Nanopartikler med en jernoxidholdig kerne omgivet af mindst to skaller
ZA951299B (en) 5-substituted derivatives of mycophenolic acid
ZA956005B (en) Iron-containing nanoparticles their production and their use for diagnostic and therapeutic purposes
HUP0201757A2 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
GB2116424B (en) Water soluable glass articles, their manufacture, and their use in the treatment of ruminant animals
ZA951292B (en) 4-amino derivatives of mycophenolic acid
ATE530168T1 (de) Magnetische nanoteilchen-zusammensetzungen und ihre verwendungen
ZA951295B (en) 6-substituted mycophenolic acid and derivatives
EP0979656A3 (en) Composition containing radioisotopes immobilised on solid particles, and its use in brachytherapy
NO20034437D0 (no) Gangliosid-assosierte rekombinante antistoffer og anvendelse derav ved diagnostikk og behandling av tumorer
AU1264200A (en) Use of neoangiogenesis markers for diagnosing and treating tumours by therapy
WO2005054295A3 (en) Therapeutic and diagnostic anti-hsp 70 antibodies
WO2000009691A3 (en) Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
CA2098113A1 (en) Substances of polypeptide nature useful in human therapy
MXPA03003011A (es) Metodos para inducir muerte de celulas cancerosas y regresion de tumores.
EP0983352A4 (en) PROSTATE-SPECIFIC REGULATORY NUCLEIC ACID SEQUENCES AND TRANSGENIC ANIMALS EXPRESSING PROSTATE-SPECIFIC ANTIQUE
SI0745072T1 (en) 4-amino derivatives of 5-substituted mycophenolic acid
AU2001289930A1 (en) Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
IL142311A0 (en) Methods and compositions for the diagnosis and therapy of prostate cancer
CN2233272Y (zh) 隐形保健麻将
Healer Rola Sheikh
PT979093E (pt) Agente viral terapeutico que interrompe o desenvolvimento de tumores
Ryasenko et al. Influence of Cs and Sr isotopes on blood producing tissue of animals in 30-km Chernobyl zone
Stonesifer The Roofer